Wataru Ichikawa - Concepedia

Author

Wataru Ichikawa

Showa University Fujigaoka Hospital ORCID

Also Known As

I. Wataru, Iwata Wataru, M Takeuchi, Masashi Fujii, Roger Sidhu, W Ichikawa, W. Ichikawa, WATARU ICHIKAWA, Wataru ICHIKAWA, Wataru Ichikawa

281

Publications

3.6K

Citations

H-Index

Concepts

All Affiliations

Showa University Fujigaoka Hospital Saitama Medical University Tokyo Medical and Dental University Nihon University Kitasato University

About

Wataru Ichikawa is an author at Showa University Fujigaoka Hospital specializing in medicine, oncology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	35	1.2K
2	Cell Biology	8	8	250
3	Natural Sciences	4	4	159
4	Health Sciences	3	3	86
5	Biochemistry	1	1	72

Wataru Ichikawa

Publications

3.1K

Citations

H-Index

Page 1

	Year	Citations
Addition of Docetaxel to Oral Fluoropyrimidine Improves Efficacy in Patients With Stage III Gastric Cancer: Interim Analysis of JACCRO GC-07, a Randomized Controlled Trial Kazuhiro Yoshida, Yasuhiro Kodera, Mitsugu Kochi, Journal of Clinical Oncology	2019	381
Impact of Expression of Human Epidermal Growth Factor Receptors EGFR and ERBB2 on Survival in Stage II/III Gastric Cancer Masanori Terashima, Koji Kitada, Atsushi Ochiai, Clinical Cancer Research	2012	225
Combination of dihydropyrimidine dehydrogenase and thymidylate synthase gene expressions in primary tumors as predictive parameters for the efficacy of fluoropyrimidine-based chemotherapy for metastatic colorectal cancer. Wataru Ichikawa, Hiroyuki Uetake, Yoshinori Shirota, PubMed Surgical OncologyFluoropyrimidine-based ChemotherapyMedicinePharmacologyPathology	2003	154
Depth of invasion parallels increased cyclooxygenase-2 levels in patients with gastric carcinoma Ryo Ohno, Keigo Yoshinaga, Takeshi Fujita, Cancer	2001	135
Both gene expression for orotate phosphoribosyltransferase and its ratio to dihydropyrimidine dehydrogenase influence outcome following fluoropyrimidine-based chemotherapy for metastatic colorectal cancer Wataru Ichikawa, Hiroyuki Uetake, Yoshinori Shirota, British Journal of Cancer	2003	128
Size- and invasion-dependent increase in cyclooxygenase 2 levels in human colorectal carcinomas. M. Matsui, Kazuaki Takaku, Hiroyuki Uetake, PubMed	1998	124
Association of UGT2B7 and ABCB1 genotypes with morphine-induced adverse drug reactions in Japanese patients with cancer Ken‐ichi Fujita, Wataru Yamamoto, Toshimichi Miya, Cancer Chemotherapy and Pharmacology Oncogenic AgentMedicinePharmacologyAbcb1 GenotypesPathology	2009	102
Alterations and hypermethylation of thep14ARF gene in gastric cancer Satoru Iida, Yoshimitsu Akiyama, Tomoko Nakajima, International Journal of Cancer	2000	84
Thymidylate synthase predictive power is overcome by irinotecan combination therapy with S-1 for gastric cancer Wataru Ichikawa, Takehiro Takahashi, K. Suto, British Journal of Cancer	2004	83
Three-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 plus docetaxel versus S-1 alone in stage III gastric cancer: JACCRO GC-07 Yoshihiro Kakeji, Kazuhiro Yoshida, Yasuhiro Kodera, Gastric Cancer Surgical OncologyThree-year OutcomesGastrointestinal OncologyMedicineJaccro Gc-07	2021	82

Page 1